Univariate analysis of clinical, biochemical, and ECG predictors of cardiac death or AMI (n = 213)
| Relative frequency of death or AMI (%) | p Value | ||
|---|---|---|---|
| Male sex | Yes/No | 16.4/20.9 | 0.41 |
| Age ⩾65 years | Yes/No | 29.3/9.1 | 0.0002 |
| Smoking (past or current) | Yes/No | 16.4/20.0 | 0.43 |
| Diabetes mellitus | Yes/No | 32.0/14.7 | 0.01 |
| Arterial hypertension | Yes/No | 25.0/14.5 | 0.06 |
| Previous angina (>4 weeks) | Yes/No | 19.1/15.6 | 0.54 |
| Previous MI | Yes/No | 27.2/10.7 | 0.003 |
| Previous revascularisation | Yes/No | 8.0/20.0 | 0.07 |
| Congestive heart failure | Yes/No | 41.7/14.8 | 0.0004 |
| Admission use of β blockers | Yes/No | 24.5/12.6 | 0.02 |
| Admission use of calcium blockers | Yes/No | 19.4/17.2 | 0.57 |
| Admission use of diuretics | Yes/No | 36.4/13.0 | 0.0002 |
| Admission ECG | |||
| ST elevation | Yes/No | 22.0/17.6 | 0.67 |
| ST depression | Yes/No | 26.8/13.4 | 0.01 |
| T wave inversion | Yes/No | 18.5/16.9 | 0.86 |
| Any ST-T change | Yes/No | 19.0/15.0 | 0.55 |
| Troponin T ⩾0.10 μg/l | Yes/No | 29.3/9.1 | 0.0003 |
| ST-VM ⩾1 episodes | Yes/No | 29.0/12.5 | 0.0006 |
| Study drug (inogatran) | Yes/No | 19.7/11.8 | 0.16 |